Help Pharmaceuticals

Help Pharmaceuticals

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

HELP Pharmaceuticals is a well-established, privately-held European CDMO and generic drug manufacturer headquartered in Athens, Greece. With over 50 years of operation, the company has evolved from a local family business into a globally recognized partner, combining state-of-the-art R&D with manufacturing excellence across sterile and non-sterile dosage forms. Its core business model revolves around providing high-quality, affordable pharmaceutical solutions and flexible manufacturing services to partners worldwide, underpinned by strong scientific rigor, a diverse product portfolio, and a presence in more than 50 countries. The company is in a mature, revenue-generating commercial stage.

Generic Drugs

Technology Platform

Integrated pharmaceutical CDMO platform utilizing QbD development, EU-GMP certified manufacturing for multiple dosage forms (sterile/non-sterile, liquid, semi-solid, solid), and a full ICH Q10-aligned quality management system for pharmaceuticals, medical devices, nutraceuticals, and cosmeceuticals.

Opportunities

The growing global demand for cost-effective generic medicines and the trend of pharmaceutical outsourcing present significant opportunities.
HELP's EU-GMP certification and diverse manufacturing capabilities allow it to capture CDMO business from companies seeking high-quality European production.
Further expansion into emerging markets and the wellness sector (nutraceuticals/cosmeceuticals) offers additional growth avenues.

Risk Factors

The company faces intense competition from larger global players, regulatory risks associated with maintaining complex international certifications, and vulnerability to supply chain disruptions and cost inflation.
Its revenue is also partially dependent on the pipelines and success of its external licensing and CDMO partners.

Competitive Landscape

HELP competes in the crowded global generic drug and CDMO markets against large multinational firms (e.g., Teva, Sandoz, Viatris) and other regional CDMOs. Its differentiation is based on high-quality EU manufacturing, flexibility, a diverse multi-format portfolio, and a strong partnership ethos, though it lacks the scale and capital resources of its largest competitors.